The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells
Open accessAbstract
The advantages of using induced pluripotent stem cells (iPSCs) instead of embryonic stem (ES) cells in regenerative medicine centre around circumventing concerns about the ethics of using ES cells and the likelihood of immune rejection of ES-cell-derived tissues. However, partial reprogramming and genetic instabilities in iPSCs could elicit immune responses in transplant recipients even when iPSC-derived differentiated cells are transplanted. iPSCs are first differentiated into specific types of cells in vitro for subsequent transplantation. Although model transplantation experiments have been conducted using various iPSC-derived differentiated tissues and immune rejections have not been observed, careful investigation of the immunogenicity of iPSC-derived tissue is becoming increasingly critical, especially as this has not been the focus of most studies done so far. A recent study reported immunogenicity of iPSC- but not ES-cell-derived teratomas and implicated several causative genes. Nevertheless, some controversy has arisen regarding these findings. Here we examine the immunogenicity of differentiated skin and bone marrow tissues derived from mouse iPSCs. To ensure optimal comparison of iPSCs and ES cells, we established ten integration-free iPSC and seven ES-cell lines using an inbred mouse strain, C57BL/6. We observed no differences in the rate of success of transplantation when skin and bone marrow cells derived from iPSCs were compared with ES-cell-derived tissues. Moreover, we observed limited or no immune responses, including T-cell infiltration, for tissues derived from either iPSCs or ES cells, and no increase in the expression of the immunogenicity-causing Zg16 and Hormad1 genes in regressing skin and teratoma tissues. Our findings suggest limited immunogenicity of transplanted cells differentiated from iPSCs and ES cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
A severe combined immunodeficiency mutation in the mouse
Bosma, G. C., Custer, R. P., & Bosma, M. J. (1983) · Nature · doi:10.1038/301527a0 · Cited by 2,207
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009
Immunogenicity of induced pluripotent stem cells
Zhao, T., Zhang, Z.-N., Rong, Z., & Xu, Y. (2011) · Nature · doi:10.1038/nature10135 · Cited by 1,444
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1667 · Cited by 1,198
Variation in the safety of induced pluripotent stem cell lines
Miura, K., Okada, Y., Aoi, T., Okada, A., Takahashi, K., Okita, K., Nakagawa, M., Koyanagi, M., Tanabe, K., Ohnuki, M., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1554 · Cited by 877
The Transcriptional and Epigenomic Foundations of Ground State Pluripotency
Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., Nichols, J., Kranz, A., Francis Stewart, A., Smith, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.026 · Cited by 835
iPS cells produce viable mice through tetraploid complementation
Zhao, X.-Y., Li, W., Lv, Z., Liu, L., Tong, M., Hai, T., Hao, J., Guo, C.-L., Ma, Q.-W., Wang, L., et al. (2009) · Nature · doi:10.1038/nature08267 · Cited by 777
The Technique of Free Skin Grafting in Mammals
Billingham, R. E., & Medawar, P. B. (1951) · Journal of Experimental Biology · doi:10.1242/jeb.28.3.385 · Cited by 746
Tsuji, O., Miura, K., Okada, Y., Fujiyoshi, K., Mukaino, M., Nagoshi, N., Kitamura, K., Kumagai, G., Nishino, M., Tomisato, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910106107 · Cited by 518
Self-citationAscorbic Acid Enhances Differentiation of Embryonic Stem Cells Into Cardiac Myocytes
Takahashi, T., Lord, B., Schulze, P. C., Fryer, R. M., Sarang, S. S., Gullans, S. R., & Lee, R. T. (2003) · Circulation · doi:10.1161/01.cir.0000064899.53876.a3 · Cited by 477
Adult mice generated from induced pluripotent stem cells
Boland, M. J., Hazen, J. L., Nazor, K. L., Rodriguez, A. R., Gifford, W., Martin, G., Kupriyanov, S., & Baldwin, K. K. (2009) · Nature · doi:10.1038/nature08310 · Cited by 463
iPS Cells Can Support Full-Term Development of Tetraploid Blastocyst-Complemented Embryos
Kang, L., Wang, J., Zhang, Y., Kou, Z., & Gao, S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.07.001 · Cited by 457
Progress toward the clinical application of patient-specific pluripotent stem cells
Kiskinis, E., & Eggan, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40553 · Cited by 339
Carey, B. W., Markoulaki, S., Hanna, J. H., Faddah, D. A., Buganim, Y., Kim, J., Ganz, K., Steine, E. J., Cassady, J. P., Creyghton, M. P., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.11.003 · Cited by 325
Tucker, B. A., Park, I.-H., Qi, S. D., Klassen, H. J., Jiang, C., Yao, J., Redenti, S., Daley, G. Q., & Young, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018992 · Cited by 308
Stadtfeld, M., Apostolou, E., Ferrari, F., Choi, J., Walsh, R. M., Chen, T., Ooi, S. S. K., Kim, S. Y., Bestor, T. H., Shioda, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.1110 · Cited by 238
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment.
Patten, P. E. M., Buggins, A. G. S., Richards, J., Wotherspoon, A., Salisbury, J., Mufti, G. J., Hamblin, T. J., & Devereux, S. (2008) · Blood · doi:10.1182/blood-2007-08-108605 · Cited by 196
Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase
Huang, T.-T., Naeemuddin, M., Elchuri, S., Yamaguchi, M., Kozy, H. M., Carlson, E. J., & Epstein, C. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl034 · Cited by 190
Morizane, A., Doi, D., Kikuchi, T., Nishimura, K., & Takahashi, J. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22547 · Cited by 170
Concise Review: Embryonic Stem Cells Versus Induced Pluripotent Stem Cells: The Game Is On
Puri, M. C., & Nagy, A. (2012) · STEM CELLS · doi:10.1002/stem.788 · Cited by 162
Concise Review: Genomic Stability of Human Induced Pluripotent Stem Cells
Martins‐Taylor, K., & Xu, R. (2011) · Stem Cells · doi:10.1002/stem.705 · Cited by 154
Creation of Engineered Cardiac Tissue In Vitro From Mouse Embryonic Stem Cells
Guo, X., Zhao, Y., Hai-xia, C., Wang, C., Lingling, E., Zhang, X., Duan, C., Dong, L., Jiang, H., Li, J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.583039 · Cited by 151
Immunogenicity of Induced Pluripotent Stem Cells
Okita, K., Nagata, N., & Yamanaka, S. (2011) · Circulation Research · doi:10.1161/res.0b013e318232e187 · Cited by 131
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection
Moine, A. L., Flamand, V., Demoor, F.-X., Noël, J., Surquin, M., Robert Kiss, A., Nahori, M., Pretolani, M., Goldman, M., & Abramowicz, D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5504 · Cited by 121
Dressel, R., Schindehütte, J., Kuhlmann, T., Elsner, L., Novota, P., Baier, P. C., Schillert, A., Bickeböller, H., Herrmann, T., Trenkwalder, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002622 · Cited by 119
Chen, Y. T., Venditti, C. A., Theiler, G., Stevenson, B. J., Iseli, C., Gure, A. O., Jongeneel, C. V., Old, L. J., & Simpson, A. J. G. (2005) · PubMed · Cited by 84
Crucial Role of C-Myc in the Generation of Induced Pluripotent Stem Cells
Araki, R., Hoki, Y., Uda, M., Nakamura, M., Jincho, Y., Tamura, C., Sunayama, M., Ando, S., Sugiura, M., Yoshida, M. A., et al. (2011) · Stem Cells · doi:10.1002/stem.685 · Cited by 67
Self-citationBubnic, S., Nagy, A., & Keating, A. (2005) · Hematology · doi:10.1080/10245330500093468 · Cited by 33
Baruah, P., Simpson, E., Dumitriu, I. E., Derbyshire, K., Coe, D., Addey, C., Dyson, J., Chai, J., Cook, T. H., Scott, D. M., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200940158 · Cited by 26
Jincho, Y., Araki, R., Hoki, Y., Tamura, C., Nakamura, M., Ando, S., Kasama, Y., & Abe, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115915 · Cited by 18
Self-citation
Cited by
Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges
Yamanaka, S. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.09.014 · Cited by 1,213
Regenerative medicine: Current therapies and future directions
Mao, A. S., & Mooney, D. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508520112 · Cited by 941
Freedman, B. S., Brooks, C. R., Lam, A. Q., Fu, H., Morizane, R., Agrawal, V., Saad, A. F., Li, M. K., Hughes, M. R., Werff, R. V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9715 · Cited by 780
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L., & Wu, J. C. (2013) · Nature Medicine · doi:10.1038/nm.3267 · Cited by 727
Alzheimer’s disease and its treatment by different approaches: A review
Srivastava, S., Ahmad, R., & Khare, S. K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113320 · Cited by 467
Metadata
- Authors
- Araki, R., Uda, M., Hoki, Y., Sunayama, M., Nakamura, M., Ando, S., Sugiura, M., Ideno, H., Shimada, A., Nifuji, A., & Abe, M.
- Venue
- Nature
- Published
- 2013-01-09
- Volume
- 494
- Issue
- 7435
- Pages
- 100-104
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2152793450
- Cited by
- 505
- References
- 37
- FWCI
- 35.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.